• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Goldman Sachs spinoff Juven to back African high-growth companies with large checks

October 6, 2021 by David Barret Leave a Comment

Mauritius and U.K.-based investment company Juven went live today with plans to fund growth-stage technology and consumer companies in Africa.

The one-year-old firm is looking to invest large checks in companies “that have proven business models, strong revenue traction and large addressable markets,” it said in a statement.

Juven is one of the few investment firms targeting growth deals on the continent, including TLcom, Novastar and Partech Africa, that have written significant checks in tech companies in recent years. 

But unlike the others, Juven is not a venture capital fund; the evergreen investment company is a spinoff from Goldman Sachs’ Africa principal team responsible for making several high-growth investments in the tech scene since 2014.

Juven founder Jules Frebault led this team (also known as the Special Situations Group). He joined Goldman Sachs in 2010 and grew out the department’s strategy from a Johannesburg office to back companies that could make good returns on the continent.

The team first made some investments across private equity and credit; the most notable bets were in telecom-led businesses and towers like the IHS Towers.

Down the line, Goldman Sachs dipped its hand into growth-stage investing in tech companies, backing Africa’s first unicorn Jumia, Zipline, and Eat’N’Go. It also led investments in Unicaf’s Series B round, Jumo’s second Series B, Kobo360’s Series A, and Twiga Foods’ Series B round.

South African fintech startup Jumo raises second $50M+ VC round

Frebault tells TechCrunch that the Juven team spun out off Goldman Sachs to “go after the growth-stage opportunity in Africa with a dedicated structure, capital, resources and mandate.”

Thus, Goldman Sachs transferred its growth portfolio — Unicaf, Jumo, Kobo360, Twiga, and Eat’N’Go — to Juven. Some former Goldman Sachs employees also left with Frebault to build out Juven’s operations.

The firm is structured to have a holding company and a balance sheet that holds its assets in cash. This way, when an investment is monetized, the capital comes back and Juven redeploys it. Such methods allow for making multiple investments without raising a dedicated fund.

“It’s actually akin to a corporate in terms of how it’s structured,” Frebault said. “And the capital that we deploy either comes from our balance sheet or we take on follow-on investments from our shareholders.” 

In that light, Juven has re-invested in four companies in its current portfolio this year. Though it plans to add more investments before the next year runs out, Frebault says the firm might not make more than three investments per year.

The average ticket size will range from $10 million to $30 million, then $50 million or more in follow-on checks. The founder says that for tech companies, which is one of Juven’s primary targets, it targets Series B and later-stage growth rounds.

Since Juven makes only a handful of investments per year, the firm will provide additional benefits around financial, legal, operational and strategic support.

“We have to be flexible and start at $10 million because it can be the right size for Series B rounds on the continent,” Frebault said. “We don’t take a venture capital approach, and we don’t invest in many companies. We take concentrated positions and then continue investing in these companies over time.”

Juven’s focus is on entrepreneurs trying to leverage tech to solve problems around access for the masses, the company said. Frebault adds that Juven may also consider non-tech companies that can solve such problems.

Although the firm says it can invest in almost anything, businesses solving problems around food, education, healthcare, financial services, commerce and logistics will most likely get a nod before others.

“We can invest in everything but we’re staying away from is extractive industries,” the founder said.

It’s the same situation with countries as the investment firm has a preference for businesses expanding regionally in large consumer economies like Nigeria, Kenya, Egypt, South Africa, Ghana and the Ivory Coast.

Even though the team that led Goldman Sachs’ investments in Africa is now at Juven, Frebault says the 152-year-old investment giant’s Asset Management division still has a global mandate that includes Africa, albeit focusing on a much larger scale and institutional activity.

Goldman Sachs declined to comment on Frebault’s move, Juven’s activity, its own broader objectives or plans for the region in the future.

What we know (and don’t) about Goldman Sachs’ Africa VC investing

Source Link Goldman Sachs spinoff Juven to back African high-growth companies with large checks

David Barret
David Barret

Related posts:

  1. Apple M1X MacBook Pro might drop as early as October
  2. Monte dei Paschi prepares to close 50 branches – letter to unions
  3. Billions blown as Macau casino investors fold amid gambling review
  4. Cyclone Shaheen approaches Oman, flights delayed

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Man Broke Down Wall In His Basement And Discovered An Ancient Underground City That Once Housed 20,000 People
  • Same-Sex Penguin Couple Adopt And Raise Chick – And They’ve All Got 10/10 Names
  • Dolphins May Not “See” With Echolocation, But Instead “Feel” With It
  • Confirmed! Comet 3I/ATLAS Is Indeed An Interstellar Visitor, Quite Different From Its Predecessors
  • At 192, Jonathan – The Oldest Living Land Animal – Has Lived Through 40 US Presidents
  • 300,000-Year-Old Wooden Tools “Made By Denisovans” Discovered In China
  • Why Do Cats Eyes Glow? For The Same Reason Great White Sharks’ Do, Silly
  • G-astronomical News: Michelin-Starred Meal To Be Served On The ISS
  • In 2032, Earth May Witness A Once-In-5,000-Year Event On The Moon
  • Brand New Microscope Designed For Underwater Reveals Stunning Details Of Corals
  • The Atlantic’s Major Circulation Current Is Showing Worrying Signs, But Is Collapse Near?
  • “The Rings Held The Answer”: How We Finally Figured Out Saturn’s Day Length In 2019
  • Mystery Of Leonardo Da Vinci’s “Vitruvian Man” Solved By A Dentist And A Protractor
  • Asteroid Ryugu’s Latest Mineral Is As Weird As Finding “A Tropical Seed In The Arctic”
  • IFLScience The Big Questions: Are We Living Through A Sixth Mass Extinction?
  • Alien Abduction Or A Trick Of The Mind? A Down To Earth Explanation Of Close Encounters
  • Six Months Into Trump’s Presidency, Americans Report Record Low Pride In Being American
  • TikToker Unknowingly Handles Extremely Venomous Cone Snail And Lives To Tell The Tale
  • Scientists Sequence Oldest Egyptian DNA To Date, From A Whopping 4,800 Years Ago
  • “Uncharted Waters”: Large Hadron Collider Begins Colliding Oxygen For The First Time
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version